VALIDATION OF MICRORNA AND INFLAMMATORY GENE BIOMARKERS THAT PREDICT PROGNOSIS AND THERAPEUTIC OUTCOME IN LUNG AND COLON ADENOCARCINOMA

The Geneva Foundation

Investigators